Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 10 Key Players companies in Imipenem
by Most Research Publications in the United States in 2021

The Imipenem top 10 is Discovery PatSnap’ annual ranking of the top 10 Most Research Publications Imipenem Key Players in the United States. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2021, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Imipenem (Primaxin among others) is an intravenous β-lactam antibiotic discovered by Merck scientists Burton Christensen, William Leanza, and Kenneth Wildonger in the mid-1970s. Carbapenems are highly resistant to the β-lactamase enzymes produced by many multiple drug-resistant Gram-negative bacteria, thus play a key role in the treatment of infections not readily treated with other antibiotics.
#
Company Name
Region
Tech Topics
Total
1
Health care,Biopharmaceutical,Drug,
...[+2]
Literature: 83
2
Health care,National security,Health Insurance Portability and Accountability Act,
...[+2]
Literature: 46
3
Health Management Associates
Literature: 42
4
Memorial Hospital & Health System
Health care,Hospitality industry,Childbirth,
...[+2]
Literature: 40
5
Penn State Milton S. Hershey Medical Center
Health care,Impella,Ventricular assist device,
...[+2]
Literature: 27
6
Health care,Clinical trial,Drug,
...[+2]
Literature: 25
7
Medical school,Clinical research,Health care,
...[+2]
Literature: 17
8
Medicine,Health care,Oncology drugs,
...[+2]
Literature: 16
9
Adjuvant,Association (object-oriented programming),Drug,
...[+2]
Literature: 11
10
Literature: 11
Page generation time: Apr 27 2025